These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 28323309)
21. [Nephropathy induced by a contrast medium--comments on risk factors and prevention]. Aurell M; Boijsen M Lakartidningen; 1992 Jun; 89(24):2180. PubMed ID: 1630247 [No Abstract] [Full Text] [Related]
27. Contrast media induced nephropathy: a literature review of the available evidence and recommendations for practice. Deek H; Newton P; Sheerin N; Noureddine S; Davidson PM Aust Crit Care; 2014 Nov; 27(4):166-71. PubMed ID: 24461960 [TBL] [Abstract][Full Text] [Related]
28. Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency. Yoshida S; Kamihata H; Nakamura S; Senoo T; Manabe K; Motohiro M; Sugiura T; Iwasaka T J Cardiol; 2009 Oct; 54(2):192-8. PubMed ID: 19782255 [TBL] [Abstract][Full Text] [Related]
29. Risk factors and therapy strategies for contrast-induced nephropathy. Toprak O; Cirit M Ren Fail; 2006; 28(5):365-81. PubMed ID: 16825085 [TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of contrast-induced nephropathy. Heinrich M; Uder M AJR Am J Roentgenol; 2005 Oct; 185(4):1079; author reply 1079. PubMed ID: 16177439 [No Abstract] [Full Text] [Related]
31. [Contrast nephropathy and its prevention]. Skulec R; Bĕlohlávek J; Kovárník T; Linhart A; Aschermann M Vnitr Lek; 2003 Feb; 49(2):127-33. PubMed ID: 12728580 [TBL] [Abstract][Full Text] [Related]
33. Contrast-induced nephropathy: does it really exist? Buckenham TM N Z Med J; 2009 Jul; 122(1299):5-6. PubMed ID: 19684640 [No Abstract] [Full Text] [Related]
34. A closer look at radiocontrast-induced nephropathy. Brezis M; Epstein FH N Engl J Med; 1989 Jan; 320(3):179-81. PubMed ID: 2911296 [No Abstract] [Full Text] [Related]
35. Water for contrast-induced nephropathy? A thirst for knowledge. Pate GE; Webb JG J Invasive Cardiol; 2003 Dec; 15(12):703-5. PubMed ID: 14660822 [No Abstract] [Full Text] [Related]
36. [Progression prevention, diagnosis, and treatment of contrast agent-induced nephropathy]. Potekhin NP; Nikitin AV; Evsiukov KB; Klopotskiĭ SA; Zaĭtseva EA Voen Med Zh; 2009 Jun; 330(6):27-32. PubMed ID: 19791685 [No Abstract] [Full Text] [Related]
38. Contrast media nephropathy--how to diagnose and how to prevent? Solomon R Nephrol Dial Transplant; 2007 Jul; 22(7):1812-5. PubMed ID: 17449491 [No Abstract] [Full Text] [Related]
39. Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients? A before-after study. Shah SJ; Hsu CY Am J Med; 2004 Dec; 117(12):948-52. PubMed ID: 15629734 [No Abstract] [Full Text] [Related]
40. [Review of the radiocontrast nephropathy risk profiles and risk stratification]. Toprak O; Cirit M; Bayata S; Yeşil M Anadolu Kardiyol Derg; 2004 Dec; 4(4):331-5. PubMed ID: 15590363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]